Dernières nouvelles pour Purple Biotech (NASDAQ:PPBT) Stock

Purple Biotech

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech Ltd

Citigroup analyst Samantha Semenkow maintains Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) with a Buy and lowers the price target from $8 to $4.

News

Price Target

Analyst Ratings

ALLO

Citigroup Maintains Buy on Allogene Therapeutics, Lowers Price Target to $4

As of May 15, 2025, two stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the<a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">NRG Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>)</h3>
<ul class="wp-block-list">
<li>On May 12, NRG Energy reported better-than-expected first-quarter financial results. &#8220;NRG achieved exceptional financial and operational performance in the first quarter. Every part of our organization operated at a high level to meet customer and market needs amidst the backdrop of increasing power demand,&#8221; said Larry Coben, Chair, President, and Chief Executive Officer. The company's stock jumped around 58% over the past month and has a 52-week high of $158.66.</li>
<li>RSI Value: 77.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>NRG Price Action: Shares of NRG Energy fell 1.9% to close at $153.81 on Wednesday.</li>
<li>Edge Stock Ratings: 96.57 Momentum score with Value at 31.10. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/NRG"><img loading="lazy" decoding="async" width="488" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15063200/image-175.png" alt="" class="wp-image-916307" style="width:329px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15063200/image-175.png 488w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15063200/image-175-300x106.png 300w" sizes="(max-width: 488px) 100vw, 488px" /></a></figure>
<h3 class="wp-block-heading">Oklo Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>)</h3>
<ul class="wp-block-list">
<li>On May 13, Oklo reported a year-over-year increase in first-quarter EPS results. Oklo also announced the appointment of Pat Schweiger as chief technology officer. Schweiger is a veteran executive and engineer who previously held leadership roles across the advanced fission and fusion industries. The company's stock gained around 61% over the past month and <a href="https://www.benzinga.com/quote/OKLO">has a 52-week high</a> of $59.14.</li>
<li>RSI Value: 78</li>
<li>OKLO Price Action: Shares of OKLO gained 15.6% to close at $37.01 on Wednesday.</li>
</ul>
How do other stocks rank? Get the full <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">BZ Edge Rankings breakdown here</a>. 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock">Jim Cramer: SoFi Goes To &#8216;New Highs,&#8217; Recommends Not Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

OKLO

Top 2 Utilities Stocks You May Want To Dump In May

CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) ("CNEY" or the "Company") is pleased to announce the approved 1-for-25 stock split of the Company's Class A ordinary shares with no par value, effective at 12:01 a.m. Eastern Time on May 19, 2025 (the "Reverse Stock Split"). The Class A ordinary shares will continue to be traded on the Nasdaq Capital Market on a split-adjusted basis beginning on May 19, 2025, under the Company's existing trading symbol "CNEY" with the new CUSIP number G2181K204.
The Reverse Stock Split is primarily intended to increase the market price per share of the Company's Class A ordinary shares to regain compliance with the minimum bid price required for continued listing on the Nasdaq Capital Market.
The Reverse Stock Split will reduce the number of Class A ordinary shares issued and outstanding from approximately 75.28 million to approximately 3.01 million. No fractional shares will be issued in connection with the Reverse Stock Split. Any amount of fractional shares will be rounded up to the next nearest number at the participant level.

Stock Split

CNEY

CN Energy Group Announces 1-for-25 Reverse Stock Split Effective May 19, 2025, Reducing Outstanding Class A Shares from 75.28M To 3.01M To Regain Nasdaq Compliance

WIIM

ONCO

Onconetix shares are trading lower after the company announced it received a Staff delisting letter from the Nasdaq .

TVAIU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

B of A Securities analyst Federico Merendi maintains Phinia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHIN#NYSE">PHIN</a>) with a Buy and raises the price target from $53 to $55.

PHIN

B of A Securities Maintains Buy on Phinia, Raises Price Target to $55

Swiss bank Sygnum&#8217;s move to accept staked Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) as loan collateral failed to stop a 5% slide in Solana&#8217;s price, which <a href="https://www.benzinga.com/money/how-to-buy-solana-meme-coins#:~:text=To%20buy%20Solana%20(SOL)%20meme,Raydium%2C%20Orca%2C%20or%20Meteora.">dipped to $170 on May 15</a> amid profit‑taking after last week&#8217;s rally.&nbsp;
Traders who piled into SOL during its surge toward $181 booked gains once broader market sentiment turned cautious. The dip comes amid real‑world integrations of SOL, and anticipation of strengthening Institutional demand.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase</li>
</ul>
Thursday's pullback did little to dull Solana&#8217;s momentum in other areas. The Crypto Fear &amp; Greed Index eased from 74 to 71 as altcoins cooled off, but institutional and developer activity hit new highs. Total value locked in Solana DeFi climbed from $7.5 billion to $9.6 billion in early May.&nbsp;
Weekly on‑chain fees topped $50 million—granting Solana a 51.6% share of all dApp revenue across major blockchains. Per CoinDesk, Solana's activity underscores just how quickly it has become a DeFi revenue powerhouse.
Developers rolled out Confidential Balances on mainnet, a zero‑knowledge and homomorphic‑encryption upgrade. Solana&#8217;s privacy toolkit's boost conceals token amounts and fees on‑chain, and preserves auditability for regulators via an optional &#8220;auditor key.&#8221; The feature bridges the gap between privacy and compliance, making Solana more attractive to institutions wary of public ledgers.
Rideshare firm Lyft tapped Bee Maps, a decentralized mapping platform built on Solana&#8217;s high‑throughput network, to power more accurate, crowdsourced street‑level imagery in its app. Former NBA star, Lamar Odom, launched ODOM, an anti‑addiction meme coin on Solana designed to fund global rehabilitation programs through transparent, token‑driven philanthropy.
Thursday's sell‑off looks more like a brief hiccup than a trend shift. SOL has held support above $168 on four‑hour charts, suggesting bulls are ready to buy the dip. If profit‑taking eases and regulators clarify the rules, many traders see a path back toward $190–$200 in the coming weeks.
After Sygnum&#8217;s staking‑collateral announcement, market‑making firms quietly boosted their SOL positions ahead of year‑end staking payouts—eyeing both yield and upside from upcoming upgrades. Developers keep rolling out new DeFi protocols and NFT projects, fueling on‑chain activity and broader interest.
Macro trends like Bitcoin&#8217;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) consolidation of around $100,000 often sparks capital rotation into higher‑beta altcoins.&nbsp;
SOL&#8217;s dip to $170 Thursday looks like a speed bump, not a roadblock. It reflects routine profit‑taking rather than a shift in Solana&#8217;s long‑term trajectory. Once traders regain their appetite for risk, SOL&#8217;s next leg up may be right around the corner.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$SOL

Solana Slumps 5% to $170, Overwhelms Sygnum's Staked‑SOL Boost

Watching Deere & Co.; During Conf Call, Exec Reportedly Says Saw About $100M Of Tariff Headwinds In Q2; Expect Pre-Tax Tariff Impact Of Little Over $500M In 2025; Don't See Much Opportunity For Price Mitigation To Impact Fiscal 2025; Actions We Took Over Past 18 Months Helped Right Size New Inventory Levels

Scotiabank analyst Jonathan Goldman maintains TerraVest Industries (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TVK#TSX">TVK</a>) with a Sector Outperform and raises the price target from C$171 to C$176.

TSX:TVK

Scotiabank Maintains Sector Outperform on TerraVest Industries, Raises Price Target to C$176

Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>) has jumped over 40% in the last week, but traders are split on whether this rally has more room to run or if <a href="https://www.benzinga.com/money/pepe-price-prediction">a correction is imminent</a>.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00001358</td>
<td>$5.7 billion</td>
<td>-2.6%</td>
<td>+43.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2239</td>
<td>$33.4 billion</td>
<td>-5.2%</td>
<td>+21.5%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001488</td>
<td>$8.8 billion</td>
<td>-6.4%</td>
<td>+10.2%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: In a X <a href="https://x.com/MaxBecauseBTC/status/1922477456352547308">post</a> on May 14, MaxBecauseBTC pointed out that short-term PEPE holders, wallets that bought within the last 30 days, are beginning to climb again after four months of decline.
Historically, this kind of growth has preceded strong price moves, signaling that speculative interest is back and potentially fueling the current rally.
Despite this, Ali Martinez flagged a cautionary signal. The TD Sequential indicator on PEPE's daily chart is now flashing a sell signal, suggesting a potential near-term pullback.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The TD Sequential has been spot-on with <a href="https://twitter.com/search?q=%24PEPE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$PEPE</a> daily chart. And it's now flashing a sell signal, suggesting a potential pullback ahead. <a href="https://t.co/3aTrPUHI4A">pic.twitter.com/3aTrPUHI4A</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1922970464709751033?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, trader Koala <a href="https://x.com/trader_koala/status/1922764634018197754">remains</a> bullish. He believes the strategy for PEPE is similar to other altcoins—buy on structural breakouts and target previous highs.
 According to him, the coin has formed solid support and could soon push toward recent resistance levels.
Statistics: According to Onchain Lens, a whale <a href="https://x.com/OnchainLens/status/1922998681042813013">withdrew</a> 581.1 billion PEPE (~$7.94 million) from Binance, often a signal of long-term positioning.
Coinglss data shows shows PEPE's open interest hit an all-time high of $582 million on May 11, signaling intense market participation. It currently remains elevated at $571 million.
IntoTheBlock data shows Pepe's large transaction volume and daily active addresses down by 25.8% and 16%, respectively. 
Transactions greater than $100,000 are down from 533 to 417. 
67% of PEPE holders are in profit, while 7% are at breakeven, indicating substantial gains across the board.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45323433/pepe-pops-30-leapfrogs-meme-veterans-dogecoin-shiba-inu-in-trading-volume-and-momentum">Pepe Pops 30%, Leapfrogs Meme Veterans Dogecoin, Shiba Inu In Trading Volume And Momentum</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

Pepe Rallies 40% In 7 Days Outpaces Dogecoin, Shiba Inu: What's Next?

SCPH

scPharmaceuticals shares are trading higher after the company reported better-than-expected Q1 sales results.

B of A Securities analyst Dimple Gosa maintains NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Buy and raises the price target from $55 to $65.

B of A Securities Maintains Buy on NEXTracker, Raises Price Target to $65

<a href="https://x.com/RemarkHoldings/status/1923020519349125230" title="https://x.com/RemarkHoldings/status/1923020519349125230">https://x.com/RemarkHoldings/status/1923020519349125230</a>

MARK

Remark Holdings Posts On X "Proud to announce that @Google Public Sector has selected #RemarkAI advanced computer-vision AI technology to power key public sector projects across New York State. @GoogleAI more details to follow - Initial projects will include highway and railway safety"

B of A Securities analyst Rafe Jadrosich maintains Armstrong World Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWI#NYSE">AWI</a>) with a Buy and raises the price target from $162 to $170.

B of A Securities Maintains Buy on Armstrong World Indus, Raises Price Target to $170

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 110B Vs 111B Est.; 104B Prior

The Oncology Institute shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

While the meme coin dropped 5.61% in a day to trade at $0.2240, it's <a href="https://www.benzinga.com/money/how-to-buy-dogecoin-doge">23% growth in the past week and a 40% rise this month</a> is impressive. Dogecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) futures have received a massive spike in a week, putting DOGE back in the limelight.
Behind the growth is a mix of renewed trader interest, bullish technical indicators, and some high-profile endorsements that are making DOGE a popular investment choice.
Over the last week, Dogecoin&#8217;s futures open interest has grown by 64% from $989 million to $1.62 billion, according to Glassnode.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses</a> — no wallets, just price speculation and free paper trading to practice different strategies.</li>
<li>New to trading crypto? <a href="http://coinbase-consumer.sjv.io/m5ALXy">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
</ul>
The surge came as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was pulling back. In a market where most altcoins typically trail behind Bitcoin, Dogecoin isn't following the trend. Glassnode referred to it as a &#8220;decoupling,&#8221; a rare and bullish indicator that DOGE is following its own narrative. Dogecoin has consistently been one of the top 10 altcoins.
Raoul Pal, a former Goldman Sachs Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) executive and macro investor thinks Dogecoin might outpace Bitcoin in the next few months. For traders on the fence, such optimism from Pal is hard to ignore, and probably encouraged even more individuals to believe in DOGE's future.
But it&#8217;s not hype alone driving the rally. Technically, the 1-day chart shows a golden cross, indicating a transition from bearish to bullish territory.
As crypto analyst Trader Tardigrade breaks down, the recent golden cross between the 20-day and 50-day EMAs indicates DOGE is potentially positioning itself for another higher leg. The signal comes after months of an opposite signal, death cross, which drove the coin down last month.
According to the analyst, Dogecoin may be looking at a surge to $0.56 over the next few weeks. The macro chart suggests an ambitious belief that the coin may be nearing the peak of its third cycle, which could lead to DOGE's most explosive move. Tardigrade believes that the final price target can even be a jaw-dropping $20.&nbsp;
For the time being, everyone&#8217;s waiting to see how long this momentum will last. With futures trading sky-high, bullish technicals, and growing hype from the analysts, Dogecoin is looking at a bright future. However, only time will tell whether the ambitious predictions for the coin will become a reality or not.
More Opportunities:
<ul class="wp-block-list">
<li>Grow your IRA or 401(k) with Crypto – <a href="https://info.irafinancial.com/lp/irafi-crypto/?utm_source=benzinga.com&amp;utm_medium=affiliate&amp;utm_campaign=y2">unlock the power of alternative investments including a Crypto IRA within your retirement account</a>.</li>
<li>Trade, earn, and grow your crypto portfolio with Crypto.com — <a href="https://www.benzinga.com/go/crypto-com-signup-bonus">plus receive up to $500 worth of rewards in the most popular tokens if you're a new customer</a>.</li>
</ul>
Image: Shutterstock

DOGE

Despite Dip, Dogecoin Futures Spike 64% with Bullish Momentum Building

KDLY

Kindly MD Shares Halted On Circuit Breaker To The Upside, Stock Now Up 48.2%

Orla Mining (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ORLA#AMEX">ORLA</a>) has outperformed the market over the past 5 years by 11.04% on an annualized basis producing an average annual return of 26.01%. Currently, Orla Mining has a market capitalization of $2.93 billion. 
Buying $1000 In ORLA: If an investor had bought $1000 of ORLA stock 5 years ago, it would be worth $3,176.48 today based on a price of $9.01 for ORLA at the time of writing.
<h3>Orla Mining's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747319411_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ORLA

$1000 Invested In Orla Mining 5 Years Ago Would Be Worth This Much Today

Scotiabank analyst Andres Coello maintains Telecom Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEO#NYSE">TEO</a>) with a Sector Underperform and raises the price target from $4.5 to $8.2.

Telecom Argentina Stet - France Telecom S.A.

Scotiabank Maintains Sector Underperform on Telecom Argentina, Raises Price Target to $8.2

Press Releases

Purple Biotech Announces Research Collaboration with the Icahn School of Medicine at Mount Sinai for CAPTN-3 Tri-Specific Antibody Platform

Health Care

Purple Biotech Advances NT219 into Phase 2 Head and Neck Cancer Trial

Purple Biotech Granted New U.S. Patent for NT219 in Combination with EGFR Antibody Therapy, Enhancing Global IP Protection in Major Markets

Earnings

Purple Biotech Reports Fourth Quarter and Full-Year 2024 Financial Results

Purple Biotech Announces Three Posters Accepted for Presentation at the 2025 American Association for Cancer Research Meeting

Purple Biotech to Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Virtual Conference on April 7, 2025

Purple Biotech Announces Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 to Suppress Brain Metastasis of Colorectal Cancer

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic Cancer Patients at AACR 2025 Annual Meeting: Improved Outcomes and Significant Efficacy in Biomarker-Enriched Subgroups

Comments

Purple Biotech

Actualités

Dernières nouvelles pour Purple Biotech (NASDAQ:PPBT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL